All Pharma News
Verastem Oncology Appoints John Hayslip As Chief Medical Officer

Verastem Oncology Appoints John Hayslip As Chief Medical Officer
BUSINESSWIRE
18 Apr 2024
Share Share
Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Verastem Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BUSINESSWIRE
04 Apr 2024
Share Share
Results Reveal Negative Impact on Well-Being for People Living with LGSOC

Results Reveal Negative Impact on Well-Being for People Living with LGSOC
BUSINESSWIRE
18 Mar 2024
Share Share
Verastem survey shows toll rare cancer takes on well-being

Verastem survey shows toll rare cancer takes on well-being
Nick Paul Taylor FIERCE PHARMA
18 Mar 2024
Share Share
Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results

Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
14 Mar 2024
Share Share
Verastem Announces Multiple Oral Presentations at SGO 2024 Annual Meeting

Verastem Announces Multiple Oral Presentations at SGO 2024 Annual Meeting
BUSINESSWIRE
11 Mar 2024
Share Share
Verastem Receives Orphan Drug Designation from FDA for Avutometinib Alone

Verastem Receives Orphan Drug Designation from FDA for Avutometinib Alone
BUSINESSWIRE
05 Mar 2024
Share Share
Verastem Oncology Outlines Key 2024 Strategic Priorities

Verastem Oncology Outlines Key 2024 Strategic Priorities
BUSINESSWIRE
29 Jan 2024
Share Share
Verastem Granted Fast Track Designation for Avutometinib and Sotorasib

Verastem Granted Fast Track Designation for Avutometinib and Sotorasib
BUSINESSWIRE
18 Jan 2024
Share Share
Verastem Oncology to Participate in B. Riley Securities 4th Oncology Conference

Verastem Oncology to Participate in B. Riley Securities 4th Oncology Conference
BUSINESSWIRE
11 Jan 2024
Share Share